PortViewPortView
Nuvectis Pharma logo

Nuvectis Pharma (NVCT) Stock Analysis

NASDAQHealthcareBiotechnology

$18.25-1.02%
1-year price historyRange $5.65 – $28.53
52-week range$18.25
$5.55$29.28

Track NVCT in your portfolio for free · Portfolio tracker

What Nuvectis Pharma does

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.

Key metrics

Market cap
$595.83M
P/E (TTM)
-13.93
EPS (TTM)
$-1.31
Beta
-0.24
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$21.69
200-day avg
$14.46
52-week high
$29.28
52-week low
$5.55
CEO
Ron Bentsur

ETFs linked to NVCT

Broad-market and Healthcare sector ETFs an investor holding Nuvectis Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NVCT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NVCT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Nuvectis Pharma?
Nuvectis Pharma trades under the ticker NVCT on NASDAQ.
Which exchange is NVCT listed on?
NVCT is listed on NASDAQ.
What sector does Nuvectis Pharma operate in?
Nuvectis Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NVCT in a portfolio?
PortView shows NVCT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.